Clinical Trial Update: A Phase I/II Study of GX15-070MS in Untreated CLL [Phase 1]

View source ↗

Summary

A Phase I/II trial of GX15-070MS (obatoclax mesylate) in untreated chronic lymphocytic leukemia has completed the Phase 1 portion reported by Gemin X.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• GX15-070MS (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED